Our team of scientists has a solid track record of success in respiratory discovery projects, having delivered 23 development candidates to our clients. Our highly experienced scientists are uniquely equipped to profile compounds in vivo, leveraging a wide array of well-characterized models and a variety of administration routes, including inhalation. We can assess important endpoints, which are valid across all respiratory diseases, such as mucociliary clearance, cough and changes in lung function.
Our models are robust and reproducible, validated with clinically relevant compounds and used in conjunction with histopathology, inflammatory mediator analysis and translational biomarker development to tailor study designs that will inform your decisions.
We offer the following Asthma Models: